BRIEF published on 05/09/2025 at 16:06, 1 year 4 months ago Le groupe Vanguard révèle sa position dans Direct Line Insurance Group Groupe Vanguard Code De Prise De Contrôle Formulaire 8.3 Divulgation Des Actions Assurance Direct Line
BRIEF published on 05/09/2025 at 16:06, 1 year 4 months ago The Vanguard Group Discloses Position in Direct Line Insurance Group Form 8.3 Takeover Code Vanguard Group Shareholding Disclosure Direct Line Insurance
PRESS RELEASE published on 05/09/2025 at 16:01, 1 year 4 months ago Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc The Vanguard Group, Inc. discloses a 5.41% stake in Direct Line Insurance Group plc as of 08 May 2025. Also making disclosures on Aviva plc. No open stock-settled derivative positions reported Securities Vanguard Group Direct Line Insurance Group Plc Disclosures Aviva Plc
BRIEF published on 05/08/2025 at 15:44, 1 year 4 months ago Vanguard Group's Disclosure on Direct Line Insurance Group Takeover Code Vanguard Group Shareholding Direct Line Insurance UK Insurance Market
BRIEF published on 05/08/2025 at 15:44, 1 year 4 months ago Divulgation du groupe Vanguard sur Direct Line Insurance Group Actionnariat Groupe Vanguard Code De Prise De Contrôle Assurance Direct Line Marché De L'assurance Au Royaume-Uni
PRESS RELEASE published on 05/08/2025 at 15:39, 1 year 4 months ago Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc The Vanguard Group, Inc. discloses 5.40% ownership in Direct Line Insurance Group plc. Additional disclosure for Aviva plc. Form 8.3 filed on 08-May-2025 Form 8.3 Vanguard Group Ownership Disclosure Direct Line Insurance Aviva Plc
BRIEF published on 05/07/2025 at 16:01, 1 year 4 months ago The Vanguard Group Discloses Significant Position in Direct Line Insurance Group Investment Takeover Code Vanguard Group Stake Disclosure Direct Line Insurance
BRIEF published on 05/07/2025 at 16:01, 1 year 4 months ago Le groupe Vanguard révèle une position importante dans Direct Line Insurance Group Investissement Groupe Vanguard Code De Prise De Contrôle Divulgation Des Enjeux Assurance Direct Line
PRESS RELEASE published on 05/07/2025 at 15:56, 1 year 4 months ago Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc The Vanguard Group, Inc. discloses a 5.40% stake in Direct Line Insurance Group plc. Additional disclosures include dealings in securities and positions held Securities Dealings The Vanguard Group Inc. Stake Disclosure Direct Line Insurance Group Plc Positions Disclosed
BRIEF published on 05/05/2025 at 15:55, 1 year 4 months ago Le groupe Vanguard révèle son intérêt pour Direct Line Insurance Groupe Vanguard Code De Prise De Contrôle Divulgation Des Actions Aviva Plc Assurance Direct Line
Published on 09/11/2026 at 04:00, 5 hours 50 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 11 hours 25 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 18 hours 30 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 18 hours 50 minutes ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 09:20, 30 minutes ago Cantourage Expands Portfolio with New Cannabis Active Ingredients for Innovative Compounded Medicines
Published on 09/11/2026 at 09:05, 45 minutes ago ROHM's New High Anti-surge Chip Resistors in "SDR01 Series" Achieve 0.33W Rated Power in 0402 Size
Published on 09/11/2026 at 09:00, 50 minutes ago Homann Holzwerkstoffe publishes its 2026 half-year report
Published on 09/11/2026 at 07:00, 2 hours 50 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 2 hours 50 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 2 hours 50 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 14 hours 20 minutes ago Availability of the 2026 Interim Financial Report
